Conventional and molecular epidemiology of trimethoprim-sulfamethoxazole resistance among urinary Escherichia coli isolates (Q53915206)

22 May 2018

title

Conventional and molecular epidemiology of trimethoprim-sulfamethoxazole resistance among urinary Escherichia coli isolates (English)

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(03)00372-3

20 March 2024

0 references

1 reference

William J. Burman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14553870

20 March 2024

Peter E. Breese

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14553870

20 March 2024

Barbara E. Murray

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14553870

20 March 2024

Kavindra V. Singh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14553870

20 March 2024

Holly A. Batal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14553870

20 March 2024

Thomas D. MacKenzie

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14553870

20 March 2024

John W. Ogle

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14553870

20 March 2024

Michael L. Wilson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14553870

20 March 2024

Randall R. Reves

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14553870

20 March 2024

Philip S. Mehler

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14553870

20 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

22 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0002934303003723?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(03)00372-3

https://api.elsevier.com/content/article/PII:S0002934303003723?httpAccept=text/plain

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(03)00372-3

American Journal of Medicine

20 March 2024

published in

1 reference

22 May 2018

volume

115

1 reference

22 May 2018

issue

5

1 reference

22 May 2018

page(s)

358-364

1 reference

22 May 2018

Management of acute dysuria. A decision-analysis model of alternative strategies

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900372-3

Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900372-3

Epidemiology of drug resistance: implications for a post-antimicrobial era

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900372-3

Increasing resistance to trimethoprim-sulfamethoxazole among isolates of Escherichia coli in developing countries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900372-3

The prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in young women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900372-3

Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900372-3

Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900372-3

A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900372-3

Spectrum of disease in persons with human immunodeficiency virus infection in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900372-3

Trimethoprim-Resistant Escherichia coli in Households of Children Attending Day Care Centers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900372-3

In vitro activity of 19 antimicrobial agents against enterococci from healthy subjects and hospitalized patients and use of an ace gene probe from Enterococcus faecalis for species identification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900372-3

Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900372-3

Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900372-3

Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900372-3

Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900372-3

Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900372-3

The utilisation and economic evaluation of antibiotics prescribed in primary care.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900372-3

A population-based study of antibiotic prescriptions for Danish children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900372-3

Outpatient systemic antiinfective use by children in the United States, 1977 to 1986

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900372-3

Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900372-3

Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900372-3

Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900372-3

Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900372-3

Randomized Comparative Trial and Cost Analysis of 3-Day Antimicrobial Regimens for Treatment of Acute Cystitis in Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900372-3

Causes of the acute urethral syndrome in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900372-3

A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900372-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Antibiotic resistance in bacterial urinary tract infections, 1991 to 1997

8

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(03)00372-3

Preparation of genomic DNA from bacteria

20 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(03)00372-3

20 March 2024

Identifiers

1 reference

22 May 2018

1 reference

22 May 2018